![Rui Yin Chu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rui Yin Chu
Corporate Officer/Principal bij
DUALITY BIOTHERAPEUTICS, INC.
Profiel
Rui Yin Chu currently works at Duality Biotherapeutics, Inc., as Vice President-Translational Medicine from 2023.
Dr. Chu also formerly worked at Sanofi, as Associate Director and Cogent Biosciences, Inc., as Senior Director-Translational Medicine.
Dr. Chu received his graduate degree in 1986 and doctorate degree in 1990 from Chinese Academy of Agricultural Sciences.
Actieve functies van Rui Yin Chu
| Bedrijven | Functie | Begin |
|---|---|---|
| DUALITY BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 24-07-2023 |
Eerdere bekende functies van Rui Yin Chu
| Bedrijven | Functie | Einde |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
| COGENT BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Opleiding van Rui Yin Chu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Chinese Academy of Agricultural Sciences
 Chinese Academy of Agricultural Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duality Biotherapeutics, Inc.
 Duality Biotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-drug conjugate and therapeutics for cancer & autoimmune diseases | Health Technology |
